Ikarian Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,000
| Closed | -$58.1K | – | 119 |
|
|
2023
Q3 | $58.1K | Buy |
+4,000
| New | +$58.1K | 0.01% | 73 |
|
|
2021
Q2 | – | Sell |
-40,913
| Closed | -$914K | – | 215 |
|
|
2021
Q1 | $914K | Sell |
40,913
-100,000
| -71% | -$2.23M | 0.03% | 129 |
|
|
2020
Q4 | $3.13M | Buy |
+140,913
| New | +$3.13M | 0.14% | 55 |
|
|
2020
Q3 | – | Sell |
-16,000
| Closed | -$237K | – | 146 |
|
|
2020
Q2 | $237K | Buy |
+16,000
| New | +$237K | 0.02% | 69 |
|